Paul Moss

Publications

  1. 2020
  2. Accepted/In press
  3. Published
  4. Published
  5. Published

    "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection?

    Paul Moss, 27 May 2020, In: Immunity & Ageing. 17, 14.

    Research output: Contribution to journalArticlepeer-review

  6. Published
  7. Published
  8. Published
  9. 2019
  10. Published
  11. Published
  12. Published

    Early T cell differentiation with well-maintained function across the adult life course in sub-Saharan Africa

    David Miles, Annette Pachnio & Paul Moss, 1 Sep 2019, In: Journal of Immunology. 203, 5, p. 1160-1171 12 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
  20. 2018
  21. Published
  22. Published

    The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands

    Jianmin Zuo, Fiyaz Mohammed & Paul Moss, 16 Aug 2018, In: Frontiers in immunology. 9, 1820.

    Research output: Contribution to journalArticlepeer-review

  23. Published
  24. Published
  25. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 4 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journalArticlepeer-review

  26. E-pub ahead of print
  27. Published
  28. Published
  29. Published
  30. 2017
  31. Published
  32. Published

    Maternal effector T cells within decidua: The adaptive immune response to pregnancy?

    David Lissauer, Mark Kilby & Paul Moss, Dec 2017, In: Placenta. 60, p. 140-144

    Research output: Contribution to journalArticlepeer-review

  33. Published
  34. Published

    ULBPs: regulators of human lymphocyte stress recognition

    Jianmin Zuo, Benjamin Willcox & Paul Moss, 13 Nov 2017, In: OncoTarget.

    Research output: Contribution to journalEditorialpeer-review

  35. Published
  36. Published

    Cytomegalovirus in Patients in the Intensive Care Unit-Reply

    Paul Moss & Julian Bion, 1 Oct 2017, In: JAMA internal medicine. 177, 10, p. 1543

    Research output: Contribution to journalComment/debatepeer-review

  37. Published
  38. Published

    Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis

    Jorge Caamano, Paul Moss & Antal Rot, Jul 2017, In: Nature Immunology. 18, 7, p. 753 - 761

    Research output: Contribution to journalArticlepeer-review

  39. Published
  40. Published
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published

    The Transcription Factor Hobit Identifies Human Cytotoxic CD4(+) T Cells

    Jianmin Zuo, Paul Moss, 24 Mar 2017, In: Frontiers in immunology. 8, 325.

    Research output: Contribution to journalArticlepeer-review

  47. Published
  48. 2016
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. Published
  55. Published
  56. Published
  57. Published
  58. Published
  59. 2015
  60. Published

    TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells

    Annette Pachnio, Paul Moss, 24 Dec 2015, In: Blood. 126, 26, p. 2781-2789

    Research output: Contribution to journalArticlepeer-review

  61. Published
  62. Published

    Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

    Ceri Oldreive, Nick Davies, Anna Skowronska, Marwan Cheng Kuang Kwok, Paul Moss, Michael Griffiths, Malcolm Taylor & Tatjana Stankovic, 3 Dec 2015, Blood. American Society of Hematology, Vol. 126. p. 167 (Blood).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  63. Published
  64. E-pub ahead of print
  65. Published
  66. Published

    Elevated HbA1c levels and the accumulation of differentiated T cells in CMV(+) individuals

    Jerrald Rector, G Neil Thomas, Paul Moss & Jos Bosch, Nov 2015, In: Diabetologia. 58, 11, p. 2596-605 10 p.

    Research output: Contribution to journalArticlepeer-review

  67. Published
  68. Published
  69. Published
  70. E-pub ahead of print
  71. Published
  72. Published
  73. Published
  74. Published

    Perturbation of the normal immune system in patients with CLL

    Paul Moss, 30 Jul 2015, In: Blood. 126, 5, p. 573-81 9 p.

    Research output: Contribution to journalArticlepeer-review

  75. Published

    Health state utilities for chronic lymphocytic leukemia: importance of prolonging progression-free survival

    Paul Moss, May 2015, In: Leukemia and Lymphoma. 56, 5, p. 1320-6 7 p.

    Research output: Contribution to journalArticlepeer-review

  76. Published
  77. Published
  78. Published

    Impact of Cytomegalovirus on Long-Term Mortality and Cancer Risk After Organ Transplantation

    Philip Johnson, Paul Moss, 20 Feb 2015, In: Transplantation.

    Research output: Contribution to journalArticlepeer-review

  79. Published
  80. Published

    Primary care management of early stage chronic lymphocytic leukaemia is safe and effective

    Helen Parry, Sarah Damery, Dickens Pratt, Paul Moss, 31 Jan 2015, In: QJM. 108, 10, p. 789-794 6 p.

    Research output: Contribution to journalArticlepeer-review

  81. Published
  82. Published

    Elevated HbA(1c) levels and the accumulation of differentiated T cells in CMV(+) individuals.

    Jerrald Rector, G Neil Thomas, Victoria Burns, Paul Moss, 2015, In: Diabetologia. 58, 11, p. 2596-2605

    Research output: Contribution to journalArticlepeer-review

  83. 2014
  84. Published

    New advances in CMV and immunosenescence

    & 20 others, , Paul Moss, Jul 2014, In: Experimental gerontology. 55, p. 54-62 9 p.

    Research output: Contribution to journalArticlepeer-review

  85. Published
  86. Published
  87. Published
  88. Published
  89. Published
  90. 2013
  91. Published
  92. Published
  93. Published
  94. Published
  95. Published

    HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy

    Geothy Chakupurakal, Mark Cobbold, Vivien Mautner & Paul Moss, Oct 2013, In: Journal of Immunotherapy. 36, 8, p. 423-31 9 p.

    Research output: Contribution to journalArticlepeer-review

  96. Published

    Cytomegalovirus infection and cognitive abilities in old age

    Paul Moss, Jul 2013, In: Neurobiology of Aging. 34, 7, p. 1846-52 7 p.

    Research output: Contribution to journalArticlepeer-review

  97. Published

    Cytomegalovirus infection is associated with increased mortality in the older population

    Annette Pachnio, Paul Moss, Jun 2013, In: Aging Cell. 12, 3, p. 381-7 7 p.

    Research output: Contribution to journalArticlepeer-review

  98. Published
  99. Published
  100. Published

    Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly

    Paul Moss, 2013, In: Immunity & Ageing. 10, 1, p. 33

    Research output: Contribution to journalArticlepeer-review

  101. 2012
  102. Published
  103. Published
  104. Published
  105. Published
  106. Published
  107. Published
  108. Published

    CMV and Immunosenescence: from basics to clinics

    Mark Beswick, Jos Bosch & 18 others, , Paul Moss, Jerrald Rector, Delphine Sauce & Keith Wheatley, 2012, In: Immunity & Ageing. 9, 1, p. 23

    Research output: Contribution to journalArticlepeer-review

  109. Published
Previous 1 2 Next